Prestige Consumer Healthcare
PBH
#4654
Rank
C$3.25 B
Marketcap
C$68.75
Share price
0.75%
Change (1 day)
-19.52%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): C$4.99

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is C$5.12. In 2025 the company made an earnings per share (EPS) of C$5.43 a decrease over its 2024 EPS that were of C$6.13.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.99-8.1%
2025C$5.43-11.4%
2024C$6.13-367.08%
2023C-$2.29-138.33%
2022C$5.9911.7%
2021C$5.3613.6%
2020C$4.72-651.67%
2019C-$0.86-148.78%
2018C$1.75-83.29%
2017C$10.49437.23%
2016C$1.95-34.13%
2015C$2.9652.94%
2014C$1.94-8.11%
2013C$2.11
2011C$1.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.45 143.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
C$9.64 88.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.49 85.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.08-78.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$4.44-13.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
C$8.81 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
C$3.29-35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.56-10.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
C-$42.22-925.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
C$1.74-66.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel